Autosomal Dominant Polycystic Kidney Disease Is Not a Risk Factor for Post-transplant Diabetes Mellitus. Matched-pair Design Multicenter Study

Archives of Medical Research

Volumn 39, Issue 3, 2008, Pages 312-319

  Pietrzak Nowacka, Maria ^a   Safranow, Krzysztof ^a   Rózański, Jacek ^a   Debska Ślizień, Alicja ^b   Domański, Leszek ^a   Dziewanowski, Krzysztof ^c   Głyda, Maciej ^d   Jankowska, Magdalena ^b   Noceń, Małgorzata ^a   Pabisiak, Krzysztof ^a   Rutkowski, Bolesław ^b   Wiśniewska, Magda ^a   Ciechanowski, Kazimierz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c Regional Hospital   (Poland)

^d District Hospital   (Poland)

Author keywords

ADPKD; Post transplant diabetes; Renal transplantation

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY MASS; CADAVER DONOR; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIURESIS; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTTRANSPLANT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RISK FACTORS;

EID: 39149106761     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.10.003     Document Type: Article

References (36)

1. The polycystic kidney disease I gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 77 (1994) 881-894
2. Kimberling W.J., Kumar S., Gabow P.A., Kenyon J.B., Connolly C.J., and Somlo S. Autosomal dominant polycystic kidney disease: localisation of the second gene to chromosome 4 q13-q23. Genomics 18 (1993) 467-472
3. Joly D., Hummel A., Ruello A., and Knebelmann B. Ciliary function of polycystins: a new model for cystogenesis. Nephrol Dial Transplant 18 (2003) 1689-1692
4. Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K., San Millan J.L., et al. The polycystic kidney disease 1 (PKD 1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10 (1995) 151-160
5. Somlo S., and Ehrlih B. Human disease: calcium signaling in polycystic kidney disease. Curr Biol 11 (2001) R356-R360 6
6. Rutkowski B., Lichodziejewska-Niemierko M., Grenda R., Czekalski S., Durlik M., Lao M., et al. Report on the renal replacement therapy in Poland-2004. Gdańsk, Mak-media (2005) 14
7. Rao M., Jacob C.K., and Shastry J.C.M. Post-renal transplant diabetes mellitus-a retrospective study. Nephrol Dial Transplant 7 (1992) 1039-1042
8. Hjelmesaeth J., and Hartmann A. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 35 (2000) 562
9. Hathaway D.K., Tolley E.A., Blakely M.L., Winsett R.P., and Gaber A.O. Development of an index to predict post-transplant diabetes mellitus. Clin Transplant 7 (1994) 330-338
10. Cosio F.G., Pesavento T.E., Osei K., Henry M.L., and Ferguson R.M. Post-transplant diabetes mellitus increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59 (2001) 732-737
11. Gentil M.A., Rocha J.L., Pereira P., Algarra G.R., and Lopez R. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C. Nephron 82 (1999) 85
12. Ducloux D., Motte G., Vautrin P., Bresson-Vautrin C., Rebibou J.M., and Chalopin J.M. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 14 (1999) 1244-1246
13. de Mattos A.M., Olyaei A.J., Prather J.C., Golconda M.S., Barry J.M., and Norman D.J. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 67 (2005) 714-720
14. Hamer R.A., Chow C.H.L., Ong A.C.M., and McKane W.S. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 83 (2007) 36-40
15. Gentil M.A., Luna E., Rodriguez-Algarra G., Osuna A., Gonzalez-Molina M., Mazuecos A., et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 17 (2002) 887-891
16. Alexander J.W., Bennet L.E., and Breen T.J. Effects of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry. Transplantation 57 (1994) 871-876
17. Brenner B.M., Cohen R.A., and Milford E.L. In renal transplantation, one size may not fit all. J Am Soc Nephrol 3 (1992) 162-169
18. Harmon W.E., and Jabs K. Special issues in pediatric renal transplantation. Semin Nephrol 12 (1992) 353-363
19. Alakulppi N.S., Kyllonen L.E., Salo H.M., Partanen J., Salmela K.T., and Laine J.T. The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation. Transpl Immunol 16 (2006) 258-262
20. Brown K.M., Kondeatis E., Vaughan R.W., Kon S.P., Farmer C.K., Taylor J.D., et al. Influence of donor C3 allotype on late renal transplantation outcome. N Engl J Med 354 (2006) 2014-2023
21. Andres A., Mazuecos A., and Garcia Garcia-Doncel A.G. A disproportionately greater body weight of the recipient in regards to the donor causes chronic graft nephropathy. A study of paired kidneys. Nephrol Dial Transplant 19 Suppl 3 (2004) 21-25
22. Kaplan B., Schold J.D., and Meier-Kriesche H.U. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol 14 (2003) 2980-2984
23. Kasiske B.L., Snyder J.J., Gilbertson D., and Matos A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3 (2003) 178-185
24. Koselj M., Koselj-Kajtna M., Kreder R., and Kandus A. Posttransplant diabetes mellitus: a serious complication of immunosuppression in renal allograft recipients. Transplant Proc 34 (2002) 3003-3004
25. Pietrzak-Nowacka M., Różański J., Safranow K., Ke{ogonek}dzierska K., Dutkiewicz G., and Ciechanowski K. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus. Arch Med Res 37 (2006) 360-364
26. Vincenti F., Jensik S.C., Filo R.S., Miller J., and Pirsch J. A long term comparison of tacrolimus (FK 506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 73 (2002) 775-782
27. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
28. Roozbeh J., Mehdizadeh A.R., Razmkon A., and Malek-Hosseini S.A. Incidence of posttransplant diabetes mellitus in kidney transplantation: a single center experience. Transplant Proc 37 (2005) 3095-3097
29. Yoshimura N., Nakai I., Ohmori Y., Aikawa I., Fukuda M., Yasumura T., et al. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 12 (1988) 11-17
30. Jindal R.M. Post-transplant diabetes mellitus-a review. Transplantation 58 (1994) 1289-1298
31. Boudreaux J.P., McHugh L., Canafax D.M., Ascher N., Sutherland D.E., Payne W., et al. The impact of cyclosporine and combination immunosuppression on the incidence of post-transplant diabetes in renal allograft recipients. Transplantation 44 (1987) 376-381
32. Sumrani N., Delaney V., Ding Z., Davis R., Daskalakis P., Friedman E.A., et al. Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplant Proc 23 (1991) 1249-1250
33. Hricik D.E., Bartucci M.R., Moir E.J., Hayes J.T., and Schulak J.A. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51 (1991) 374-377
34. Pirsch J.D., Miller J., Deierhoi M.H., Vincenti F., and Filo R.S. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after cadaveric renal transplantation: FK 506 Kidney Transplant Study Group. Transplantation 63 (1997) 977-983
35. Vincenti F., Laskow D.A., Neylan J.F., Mendez R., and Matas A.J. One-year follow-up of an open-label trial of FK 506 for primary kidney transplantation: a report of the US Multicenter FK 506 Kidney Transplant Group. Transplantation 61 (1996) 1576-1581
36. Heisel O., Heisel R., Balshaw R., and Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and metaanalysis. Am J Transplant 4 (2004) 583-595